Independent biotech intelligence, written for the people who have to act on it.
The Catalyst Brief covers biotech and healthcare for founders, investors, and operators The approvals, financings, and platform shifts that change what a company should do next. Published daily across six beats. No press-release rewrites, no hype cycle.
What we cover
Regulatory & Policy
431Approvals, pathways, guidance, and the agencies that set them.
Biopharmaceutical Industry
293Deals, pipelines, earnings, and the strategy behind them.
Biotech Innovation
157Platforms and modalities moving from bench to clinic.
Healthcare Investment
146Financings, IPOs, and where capital is actually going.
Medical Technology
94Devices, diagnostics, and the tools around the drug.
AI in Drug Discovery
69Where computation is changing how molecules get found.
Who writes it
Every article is built from named public sources, checked against them before publication, and corrected in public when we get something wrong.
How we work
Independent
No sponsored coverage and no pay-to-play placement. What gets covered is decided on whether it changes a decision, not on who is asking.
Sourced
Reporting is built from primary material: agency filings, company disclosures, and trial readouts. We link to it, so you can check the claim yourself.
Corrected in the open
When something is wrong we fix it on the record rather than quietly. The standards we hold ourselves to are written down.
Get it in your inbox, every week.
One brief covering what moved across all six beats, and what it means for the decisions in front of you.
Subscribe free